Zevra Therapeutics, Inc. (ZVRA)

NASDAQ

$10.55

$+0.45

(+4.47%)

Pre-Market

Zevra Therapeutics, Inc. (ZVRA) Live Price Chart

Last updated: ⁦2026-10-20 10:50:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Zevra Therapeutics, Inc. (ZVRA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $10.55, with a market capitalization of $590.27M and a P/E ratio of 10.42. Over the past 52 weeks, its price has ranged from $8.01 to $15.04. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$590.27M
Open	$10.10
Day's High	$15.04
Day's Low	$3.89
Previous Close	$10.16
Volume	106.00
Average Volume	1.07M
P/E Ratio	10.42
52-Week High	$15.04
52-Week Low	$8.01
Dividend Yield	--
Earnings Date	--

Zevra Therapeutics, Inc. (ZVRA) Pre-Market Stock Price

Zevra Therapeutics, Inc. (ZVRA) is trading at $10.55 in pre-market trading as of 2026-10-20 08:29:00, up 3.85% ($0.39) from the previous close of $10.16

Pre-market trading shows how investors are pricing ZVRA before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Zevra Therapeutics, Inc. (ZVRA) 7-Day Stock Price Change

Over the past seven days, Zevra Therapeutics, Inc. (ZVRA) moved from $11.39 to $10.55, representing a decline of 7.37% ($0.84).

The stock traded between $9.84 and $11.46 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.

The average daily volume was 694.24 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

ZVRA 52-Week Price Position

Position in Range: 36.2%

52W Low$8.01

52W High$15.04

ZVRA is currently trading at $10.55, placing it 36.2% of the way from its 52-week low of $8.01 to its 52-week high of $15.04. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Zevra Therapeutics, Inc. (ZVRA)?

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

Zevra Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	61
Exchange	NASDAQ
Company Website	https://www.zevra.com

How to Buy Zevra Therapeutics, Inc. (ZVRA) Stock on MEXC

Eligible investors can buy real shares of Zevra Therapeutics, Inc. (ZVRA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ZVRA and Place Your Order

Open the RealStocks trading page and search for ZVRA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Zevra Therapeutics, Inc. (ZVRA) stock price today?

Zevra Therapeutics, Inc. (ZVRA) is currently trading at $ 10.55, up 3.85% ($0.39) from the previous close of $ 10.16. Intraday prices update in real time during regular trading hours.

2.Is ZVRA stock going up or down today?

As of 2026-10-20 08:29:00, ZVRA is trading at $ 10.55, up 3.85% ($0.39) from its previous close of $ 10.16. The stock has traded between $ 3.89 and $ 15.04 during today’s regular session. Past price movements do not guarantee future results.

3.What is ZVRA pre-market price?

As of 2026-10-20 08:29:00, ZVRA is trading at $ 10.55 in pre-market trading, up 3.85% ($0.39) from the previous close of $ 10.16. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ZVRA after-hours price?

As of 2026-10-20 08:29:00, ZVRA is trading at $ 10.05 in after-hours trading, down 1.08% ($0.11) from the regular-session close of $ 10.16. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ZVRA stock trading now?

ZVRA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ZVRA sit relative to its 52-week high and low?

Over the past 52 weeks, ZVRA has traded between a low of $ 8.01 and a high of $ 15.04. At $ 10.55, the stock is positioned 36.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Zevra Therapeutics, Inc. in?

Zevra Therapeutics, Inc. (ZVRA) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Zevra Therapeutics, Inc.'s market capitalization and where is it listed?

Zevra Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 590.27M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ZVRA valued in terms of P/E ratio and EPS?

ZVRA trades at a P/E ratio of 10.42, based on trailing-twelve-month EPS of $ 0.98. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Zevra Therapeutics, Inc. pay a dividend?

Zevra Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.